Reuters logo
2 个月前
BRIEF-Beigene presents preliminary Phase 1 data on BGB-A317
2017年6月29日 / 上午9点21分 / 2 个月前

BRIEF-Beigene presents preliminary Phase 1 data on BGB-A317

June 29 (Reuters) - Beigene Ltd :

* Beigene presents preliminary phase 1 data on BGB-A317 in patients with hepatocellular carcinoma at the ESMO 19th world congress on gastrointestinal cancer

* Preliminary phase 1 data suggest BGB-A317 was generally well tolerated,exhibited preliminary evidence of anti-tumor activity in HCC patients Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below